Growing community of inventors

Mont-Royal, Canada

Robert Déziel

Average Co-Inventor Count = 4.47

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 34

Robert DézielJeffrey O'Meara (6 patents)Robert DézielWilliam W Ogilvie (6 patents)Robert DézielChristiane Yoakim (3 patents)Robert DézielBruno Simoneau (2 patents)Robert DézielPierre Louis Beaulieu (1 patent)Robert DézielNeil Moss (1 patent)Robert DézielDale R Cameron (1 patent)Robert DézielJulian Adams (1 patent)Robert DézielStephen Kawai (1 patent)Robert DézielJulie Naud (1 patent)Robert DézielEric Malenfant (1 patent)Robert DézielCatherine Chabot (1 patent)Robert DézielRobert Déziel (7 patents)Jeffrey O'MearaJeffrey O'Meara (16 patents)William W OgilvieWilliam W Ogilvie (12 patents)Christiane YoakimChristiane Yoakim (44 patents)Bruno SimoneauBruno Simoneau (33 patents)Pierre Louis BeaulieuPierre Louis Beaulieu (45 patents)Neil MossNeil Moss (34 patents)Dale R CameronDale R Cameron (27 patents)Julian AdamsJulian Adams (16 patents)Stephen KawaiStephen Kawai (11 patents)Julie NaudJulie Naud (7 patents)Eric MalenfantEric Malenfant (6 patents)Catherine ChabotCatherine Chabot (6 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Boehringer Ingelheim (canada) Ltd. (6 from 62 patents)

2. Boehringer Ingelheim International Gmbh (1 from 1,537 patents)


7 patents:

1. 6716836 - Non-nucleoside reverse transcriptase inhibitors

2. 6706706 - Non-nucleoside reverse transcriptase inhibitors

3. 6673791 - Non-nucleoside reverse transcriptase inhibitors

4. 6313095 - Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain

5. 6242439 - Azetidinone derivatives for the treatment of HCMV infections

6. 6239125 - Azetidinone derivatives for the treatment of HCMV infections

7. 6211170 - Azetidinone derivatives for the treatment of HCMV infections

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…